Delayed Chemotherapy-Induced Nausea in Women Treated for Breast Cancer

scientific article published on March 1, 2003

Delayed Chemotherapy-Induced Nausea in Women Treated for Breast Cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1188/03.ONF.E40-E47
P953full work available at URLhttp://ons.metapress.com/index/H760703496561442.pdf
P698PubMed publication ID12692669

P2093author name stringJudith Luce
Karen Casey
Brenda Nussey
Jill Isreal
Suzanne L. Dibble
P2860cites workRecommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical OncologyQ33880234
Economics and health-related quality of life in antiemetic therapy: recommendations for trial designQ33994104
Treatment of chemotherapy-induced nausea and vomitingQ34286849
The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical reviewQ34465002
Improved control of emesis and quality of life with ondansetron in breast cancerQ40890387
The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients: a randomised controlled trialQ43924288
Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy. Dose, schedule, and route of administrationQ47965348
Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.Q52526734
Options in the treatment of chemotherapy-induced emesis.Q53567949
Mechanisms and management of nausea and emesisQ71221209
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectchemotherapyQ974135
P304page(s)E40-7
P577publication date2003-03-01
P1433published inOncology Nursing ForumQ15760549
P1476titleDelayed Chemotherapy-Induced Nausea in Women Treated for Breast Cancer
P478volume30

Reverse relations

cites work (P2860)
Q37190499A review of patient self-report tools for chemotherapy-induced nausea and vomiting
Q24188141Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting
Q24246243Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting
Q37337769Body image disturbance and surgical decision making in egyptian post menopausal breast cancer patients
Q43250798Casopitant improves the quality of life in patients receiving highly emetogenic chemotherapy
Q34572539Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings
Q46133386Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide
Q64929253Combination of palonosetron, aprepitant, and dexamethasone as primary antiemetic prophylaxis for cisplatin-based chemotherapy.
Q40299605Distress before chemotherapy predicts delayed but not acute nausea
Q24244208Exercise for women receiving adjuvant therapy for breast cancer
Q24246529Exercises for women receiving adjuvant therapy for breast cancer
Q41151846Guideline sheets on the side effects of anticancer drugs are useful for general practitioners
Q33652946Outcomes Associated with 5-HT3-RA Therapy Selection in Patients with Chemotherapy-Induced Nausea and Vomiting: A Retrospective Claims Analysis
Q37736060Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists
Q39224398Translation and psychometric assessment of the Persian version of the Rhodes Index of Nausea, Vomiting and Retching (INVR) scale for the assessment of chemotherapy-induced nausea and vomiting.

Search more.